Author name: Open MedScience

Open MedScience delivers expert insights in nuclear medicine, diagnostic imaging, radiotheranostics, artificial intelligence, medical physics, radiopharmaceuticals, radiation therapy, radiology, and medical devices. From PET and SPECT to AI-driven diagnostics and targeted cancer treatments, we connect professionals, researchers, and students with innovations advancing patient care, health, and wellbeing worldwide.

Gastroenteropancreatic neuroendocrine tumours challenge diagnosis, treatment, and long-term management
Radiotherapeutics

Peptide Receptor Radionuclide Therapy (PRRT): A Breakthrough in Treating Gastroenteropancreatic Neuroendocrine Tumours

Peptide Receptor Radionuclide Therapy utilises radiopharmaceuticals to target somatostatin receptor-expressing tumours, improving treatment outcomes significantly.

, ,

Peptide Receptor Radionuclide Therapy (PRRT): A Breakthrough in Treating Gastroenteropancreatic Neuroendocrine Tumours Read Article »

AI imaging revolutionises clinical diagnostics by enhancing accuracy, speed, and efficiency
Artificial Intelligence

Transforming Healthcare: AI-Powered Medical Imaging Classification

AI imaging revolutionises clinical diagnostics by enabling rapid, accurate disease detection, monitoring, and personalised treatment planning. Image for illustration only. Person depicted is a model.

, ,

Transforming Healthcare: AI-Powered Medical Imaging Classification Read Article »